ArticleClinical and molecular hepatology2025

Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues.

Rui Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.